Patient participation in Dutch ethics support: practice, ideals, challenges and recommendations-a national survey.

Clinical ethics Ethics consultation Moral Case Deliberation Netherlands Patient participation Survey

Journal

BMC medical ethics
ISSN: 1472-6939
Titre abrégé: BMC Med Ethics
Pays: England
ID NLM: 101088680

Informations de publication

Date de publication:
22 06 2022
Historique:
received: 20 01 2022
accepted: 20 05 2022
entrez: 22 6 2022
pubmed: 23 6 2022
medline: 25 6 2022
Statut: epublish

Résumé

Patient participation in clinical ethics support services (CESS) has been marked as an important issue. There seems to be a wide variety of practices globally, but extensive theoretical or empirical studies on the matter are missing. Scarce publications indicate that, in Europe, patient participation in CESS (fused and abbreviated hereafter as: PP) varies from region to region, and per type of support. Practices vary from being non-existent, to patients being a full conversation partner. This contrasts with North America, where PP seems more or less standard. While PP seems to be on the rise in Europe, there is no data to confirm this. This study sought a deep understanding of both habits and the attitudes towards PP in the Netherlands, including respondents' practical and normative perspectives on the matter. We developed a national survey on PP for Dutch CESS staff. Our survey comprised a total of 25 open and close-ended questions, focused on four topics related to PP (1) goals of CESS, (2) status quo of PP, (3) ideas and ideals concerning PP, and (4) obstacles for PP. The four most important findings were that: (1) Patient participation in Dutch CESS is far from standard. (2) Views on patient participation are very much intertwined with the goals of ethics support. (3) Hesitations, fears and perceived obstacles for PP were not on principle and (4) Most respondents see PP as a positive opportunity, yet requiring additional training, practical guidance and experience. Various normative reasons require PP. However, PP seems far from standard and somewhat rare in Dutch CESS settings. Our respondents did not raise many principled objections to PP. Instead, reasons for the lack of PP are intertwined with viewpoints on the goals of CESS, which seemingly focus on supporting health care professionals (HCPs). Training and practical guidance was thought to be helpful for gaining experience for both CESS staff and HCPs.

Sections du résumé

BACKGROUND
Patient participation in clinical ethics support services (CESS) has been marked as an important issue. There seems to be a wide variety of practices globally, but extensive theoretical or empirical studies on the matter are missing. Scarce publications indicate that, in Europe, patient participation in CESS (fused and abbreviated hereafter as: PP) varies from region to region, and per type of support. Practices vary from being non-existent, to patients being a full conversation partner. This contrasts with North America, where PP seems more or less standard. While PP seems to be on the rise in Europe, there is no data to confirm this. This study sought a deep understanding of both habits and the attitudes towards PP in the Netherlands, including respondents' practical and normative perspectives on the matter.
METHODS AND RESULTS
We developed a national survey on PP for Dutch CESS staff. Our survey comprised a total of 25 open and close-ended questions, focused on four topics related to PP (1) goals of CESS, (2) status quo of PP, (3) ideas and ideals concerning PP, and (4) obstacles for PP.
DISCUSSION
The four most important findings were that: (1) Patient participation in Dutch CESS is far from standard. (2) Views on patient participation are very much intertwined with the goals of ethics support. (3) Hesitations, fears and perceived obstacles for PP were not on principle and (4) Most respondents see PP as a positive opportunity, yet requiring additional training, practical guidance and experience.
CONCLUSIONS
Various normative reasons require PP. However, PP seems far from standard and somewhat rare in Dutch CESS settings. Our respondents did not raise many principled objections to PP. Instead, reasons for the lack of PP are intertwined with viewpoints on the goals of CESS, which seemingly focus on supporting health care professionals (HCPs). Training and practical guidance was thought to be helpful for gaining experience for both CESS staff and HCPs.

Identifiants

pubmed: 35733137
doi: 10.1186/s12910-022-00801-z
pii: 10.1186/s12910-022-00801-z
pmc: PMC9219170
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

62

Informations de copyright

© 2022. The Author(s).

Références

J Bioeth Inq. 2021 Jul;18(2):291-303
pubmed: 33638124
Philos Ethics Humanit Med. 2018 Feb 27;13(1):3
pubmed: 29482585
J Med Ethics. 2021 Aug;47(8):549-552
pubmed: 33883235
Soc Sci Med. 2006 Jan;62(1):116-24
pubmed: 15992980
Ann Intern Med. 2000 Jul 4;133(1):59-69
pubmed: 10877742
Am J Bioeth. 2015;15(1):48-9
pubmed: 25562229
Bioethics. 2017 May;31(4):246-257
pubmed: 28417518
HEC Forum. 2011 Sep;23(3):207-24
pubmed: 21792683
BMC Med Ethics. 2016 Jul 22;17(1):45
pubmed: 27448597
Nurs Ethics. 2020 Mar;27(2):390-406
pubmed: 31177947
HEC Forum. 1990;2(1):3-17
pubmed: 10103622
AMA J Ethics. 2016 May 01;18(5):546-53
pubmed: 27213887
J Med Ethics. 2011 Aug;37(8):456-60
pubmed: 21511970
Health Care Anal. 2015 Sep;23(3):238-52
pubmed: 24398556
Hastings Cent Rep. 1991 Sep-Oct;21(5):17-25
pubmed: 1743946
Health Care Anal. 2013 Dec;21(4):323-37
pubmed: 21912993
J Med Ethics. 2020 Feb;46(2):66-70
pubmed: 31488518
J Med Ethics. 2007 Sep;33(9):497-500
pubmed: 17761815
Am J Bioeth. 2007 Feb;7(2):13-25
pubmed: 17366184
HEC Forum. 2002 Mar;14(1):13-25
pubmed: 12001798
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Camb Q Healthc Ethics. 2002 Winter;11(1):87-93
pubmed: 11868423
Am J Bioeth. 2022 Apr;22(4):5-18
pubmed: 33769216
Med Health Care Philos. 2003;6(3):247-54
pubmed: 14620461
Health Care Anal. 2009 Sep;17(3):217-35
pubmed: 19139992
HEC Forum. 2022 Jun;34(2):169-186
pubmed: 33449233
Res Involv Engagem. 2020 Jun 16;6:30
pubmed: 32550002
Sci Eng Ethics. 2020 Apr;26(2):833-850
pubmed: 31587148
Qual Health Res. 2009 Mar;19(3):401-15
pubmed: 19224882

Auteurs

Marleen Eijkholt (M)

Department of Medical Ethics and Health Law, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, Netherlands. marleen.neuroethics@gmail.com.

Janine de Snoo-Trimp (J)

Department of Ethics, Law and Humanities, Amsterdam UMC, Amsterdam, Netherlands.

Wieke Ligtenberg (W)

Department of Ethics, Law and Humanities, Amsterdam UMC, Amsterdam, Netherlands.

Bert Molewijk (B)

Department of Ethics, Law and Humanities, Amsterdam UMC, Amsterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH